Nuromol, a medicine that contains 200mg of
ibuprofen and 500mg of paracetamol per tablet will become available
without the need to visit a pharmacy.
Following a public consultation, the Medicine and Healthcare
products Regulatory Agency (MHRA) is making Nuromol, a medicine
that contains 200mg of ibuprofen and 500mg of paracetamol per
tablet available without the need to visit a pharmacy.
Dr Sarah Branch, Director of Vigilance and Risk Management of
Medicines at the MHRA, said:
This reclassification to general sales list will help people to
manage their pain where paracetamol or ibuprofen alone have not
provided adequate pain relief.
Wider availability of medicinal products and improved patient
access and choice remain high on the health agenda. The MHRA is
committed to improving access to medicinal products for
self-care where it is safe to do so.
Nuromol is used for the temporary relief of mild to moderate pain
associated with migraine, headache, backache, period pain, dental
pain, rheumatic and muscular pain, pain of non-serious arthritis,
cold and flu symptoms, sore throat, and fever when paracetamol or
ibuprofen alone have not provided adequate pain relief.
While most people can take paracetamol, ibuprofen is not suitable
for everyone, and it is also important that people do not exceed
the recommended dose of 1 or 2 tablets not more than 3 times a
day. Patients are also advised not to take more than one
paracetamol-containing medicine at the same time.
The MHRA’s decision to reclassify this product follows a review
by the Commission on Human Medicines (CHM) and a public
consultation. The CHM advises ministers on the safety, efficacy
and quality of medicinal products.
The consultation response is available here
